Media
Latest News
Washington, D.C.- Congresswoman Diana Harshbarger released the following statement after her votes against Democrat-led bills that infringe upon law-abiding citizens’ Second Amendment Rights: H.R. 8, the Background Checks Act, and H.R. 1446, the Enhanced Background Checks Act of 2021.
Washington, D.C.- Congresswoman Diana Harshbarger released the following statement outlining her opposition to the Democrats’ partisan $1.9 trillion stimulus bill.
by: Slater Teague
WASHINGTON (WJHL) — Neopharma’s pharmaceutical manufacturing facility in Bristol will keep its critical infrastructure designation even after the COVID-19 pandemic is over.
That’s according to Rep. Diana Harshbarger, who announced Thursday evening that the Cybersecurity and Infrastructure Security Agency (CISA) reaffirmed the facility’s status and said it will remain in place post-pandemic.
To read the full article, please visit here.
Kingsport, TN- Congresswoman Diana Harshbarger released the following statement regarding the critical infrastructure designation for the Neopharma pharmaceutical manufacturing facility located in Bristol, TN. The plant is the only domestic turn-key facility to allow for the full production of penicillin.
Washington, D.C.- Congresswoman Diana Harshbarger released the following statement today regarding the partisan budget reconciliation proposal by President Biden and Congressional Democrats.
Kingsport, TN- Congresswoman Diana Harshbarger released the following statement today regarding her selection to the House Committee on Education and Labor and the House Committee on Homeland Security.
Washington, DC- Today, Congresswoman Diana Harshbarger released the following statement after accepting an invitation to join the House Republican Whip Team.
by: Slater Teague
Posted: Jan 12, 2021 / 03:25 PM EST / Updated: Jan 12, 2021 / 03:33 PM EST
Washington, DC- Congresswoman Diana Harshbarger released the following statement regarding efforts to remove President Trump from office prior to the conclusion of his term.




